d1000 Varejo Farma Participações S.A. (BVMF:DMVF3)
Brazil flag Brazil · Delayed Price · Currency is BRL
6.43
+0.03 (0.47%)
Last updated: May 13, 2026, 1:15 PM GMT-3

BVMF:DMVF3 Income Statement

Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,7592,6672,1611,7491,4831,141
Revenue Growth (YoY)
22.77%23.42%23.54%17.92%29.94%13.64%
Cost of Revenue
1,9641,9051,4991,1961,008770.5
Gross Profit
794.46762.25661.64552.83475.51370.9
Selling, General & Admin
715.91689.14595.35511.21437.68295.58
Other Operating Expenses
-9.78-10.793.06-9.72.2-16.61
Operating Expenses
706.13678.36598.41501.51439.88373.01
Operating Income
88.3383.8963.2451.3235.63-2.11
Interest Expense
-65.4-61.83-36.58-28.98-29.63-24.45
Interest & Investment Income
0.020.451.752.542.933.26
Other Non Operating Income (Expenses)
-2.72-2.720.051.393.854.12
EBT Excluding Unusual Items
20.2319.7828.4626.2712.78-19.19
Pretax Income
20.2319.7828.4626.2712.78-19.19
Income Tax Expense
-3.72-2.782.614.911.42-21.17
Net Income
23.9522.5725.8621.3611.361.98
Net Income to Common
23.9522.5725.8621.3611.361.98
Net Income Growth
-4.04%-12.73%21.04%88.13%473.78%1508.94%
Shares Outstanding (Basic)
515151515151
Shares Outstanding (Diluted)
515151515151
EPS (Basic)
0.470.450.510.420.220.04
EPS (Diluted)
0.470.450.510.420.220.04
EPS Growth
-4.04%-12.73%21.04%88.13%473.78%1509.38%
Free Cash Flow
91.8886.7699.2696.4968.2846.08
Free Cash Flow Per Share
1.821.711.961.911.350.91
Gross Margin
28.80%28.58%30.62%31.61%32.06%32.50%
Operating Margin
3.20%3.15%2.93%2.94%2.40%-0.18%
Profit Margin
0.87%0.85%1.20%1.22%0.77%0.17%
Free Cash Flow Margin
3.33%3.25%4.59%5.52%4.60%4.04%
EBITDA
134.55127.7998.2181.6863.4323.82
EBITDA Margin
4.88%4.79%4.54%4.67%4.28%2.09%
D&A For EBITDA
46.2243.8934.9730.3627.7925.93
EBIT
88.3383.8963.2451.3235.63-2.11
EBIT Margin
3.20%3.15%2.93%2.94%2.40%-0.18%
Effective Tax Rate
--9.16%18.69%11.13%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.